Fujii Shiro 藤井志朗

… Alternative Names

FUJII Shiro 藤井志朗

Less

Researcher Number	00618473
Affiliation (Current)	2025: 徳島大学, 病院, 講師
Affiliation (based on the past Project Information) *help	2021 – 2022: 徳島大学, 病院, 講師 2019 – 2020: 徳島大学, 病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator PIM2 / 多発性骨髄腫 / アポトーシス / 骨形成 / 骨芽細胞 / 骨髄間質細胞 / miRNA / 細胞外小胞 / 微小環境 / pHセンサー / 酸性環境

Suppression of tumor progression in multiple myeloma by osteogenic microenvironment: Elucidation of the molecular pathogenesis of tumor suppressing nichePrincipal Investigator
- Principal Investigator
  
  FUJII Shiro
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  The University of Tokushima
Elucidation of acidic metabolism in multiple myeloma and the development of novel therapies targeting its acidic microenvironment.Principal Investigator
- Principal Investigator
  
  FUJII Shiro
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  The University of Tokushima

All 2022 2021 2020 2019 2018

All Journal Article Presentation

[Journal Article] A Genome-Wide Association Study Predicts the Onset of Dysgeusia Due to Anti-cancer Drug Treatment2022
- Author(s)
  Takei M, Okada N, Nakamura S, Kagawa K, Fujii S, Miki H, Ishizawa K, Abe M, Sato Y.
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 45 Issue: 1 Pages: 114-117
- DOI
  10.1248/bpb.b21-00745
- NAID
  130008139002
- ISSN
  0918-6158, 1347-5215
- Year and Date
  2022-01-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-21H02646, KAKENHI-PROJECT-21K16244
[Journal Article] Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation2022
- Author(s)
  Fuchida Shin-ichi、Kawamura Koji、Sunami Kazutaka、Tsukada Nobuhiro、Fujii Shiro、Ohkawara Hiroshi、Usuki Kensuke、Wake Atsushi、Endo Shinya、Ishiyama Ken、Ueda Yasunori、Nakamura Yukinori、Miyamoto Toshihiro、Fukuda Takahiro、Ichinohe Tatsuo、Atsuta Yoshiko、Takamatsu Hiroyuki
- Journal Title
  
  Transplantation and Cellular Therapy
  
  Volume: 28 Issue: 2 Pages: 76-82
- DOI
  10.1016/j.jtct.2021.10.021
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16244
[Journal Article] The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease2022
- Author(s)
  Hirokazu Miki,Shingen Nakamura,Masahiro Oura,Masafumi Nakamura,Ryohei Sumitani,Kimiko Sogabe,Mamiko Takahashi,Tomoko Maruhashi,Takeshi Harada,Shiro Fujii,Hirofumi Hamano,Masateru Kondo,Naoto Okada,Itsuro Endo,Masahiro Abe
- Journal Title
  
  eJHaem
  
  Volume: － Issue: 2 Pages: 480-483
- DOI
  10.1002/jha2.402
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08712, KAKENHI-PROJECT-21K16244, KAKENHI-PROJECT-22H03104
[Journal Article] Allogeneic haematopoietic stem cell transplantation?clinical outcomes: impact of leg muscle strength2021
- Author(s)
  Kondo Shin、Kagawa Kumiko、Saito Takashi、Oura Masahiro、Sogabe Kimiko、Harada Takeshi、Fujii Shiro、Nakamura Shingen、Miki Hirokazu、Sato Nori、Ono Rei、Abe Masahiro、Katoh Shinsuke
- Journal Title
  
  BMJ Supportive & Palliative Care
  
  Volume: 1 Pages: 003256-003256
- DOI
  10.1136/bmjspcare-2021-003256
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K11345, KAKENHI-PROJECT-21K16244
[Journal Article] Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis2021
- Author(s)
  Sumitani Ryohei、Hori Taiki、Murai Jumpei、Kawata Shiyori、Oura Masahiro、Sogabe Kimiko、Takahashi Mamiko、Harada Takeshi、Fujii Shiro、Miki Hirokazu、Kagawa Kumiko、Abe Masahiro、Nakamura Shingen
- Journal Title
  
  Intern. Med.
  
  Volume: 60 Issue: 11 Pages: 1753-1757
- DOI
  10.2169/internalmedicine.4916-20
- NAID
  130008046806
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2021-06-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16244
[Journal Article] Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement2021
- Author(s)
  Takahashi Mamiko、Sumitani Ryohei、Hori Taiki、Murai Jumpei、Kawata Shiyori、Oura Masahiro、Sogabe Kimiko、Harada Takeshi、Fujii Shiro、Miki Hirokazu、Kagawa Kumiko、Abe Masahiro、Nakamura Shingen
- Journal Title
  
  The Journal of Medical Investigation
  
  Volume: 68 Issue: 1.2 Pages: 196-201
- DOI
  10.2152/jmi.68.196
- NAID
  130008038399
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16244
[Journal Article] The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.2020
- Author(s)
  1. Ashtar M, Tenshin H, Teramachi J, Bat-Erdene A, Hiasa M, Oda A, Tanimoto K, Shimizu S, Higa Y, Harada T, Oura M, Sogabe K, Nakamura S, Fujii S, Sumitani R, Miki H, Udaka K, Takahashi M, Kagawa K, Endo I, Tanaka E, Matsumoto T, Abe M.
- Journal Title
  
  Cancers (Basel)
  
  Volume: 12 Issue: 4 Pages: 929-929
- DOI
  10.3390/cancers12040929
- NAID
  120006894611
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17858, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-20K18784, KAKENHI-PROJECT-17H05104
[Journal Article] TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.2020
- Author(s)
  2. Teramachi J, Tenshin H, Hiasa M, Oda A, Bat-Erdene A, Harada T, Nakamura S, Ashtar M, Shimizu S, Iwasa M, Sogabe K, Oura M, Fujii S, Kagawa K, Miki H, Endo I, Haneji T, Matsumoto T, Abe M.
- Journal Title
  
  Haematologica
  
  Volume: haematol.2019 Issue: 5 Pages: 1401-1413
- DOI
  10.3324/haematol.2019.234476
- NAID
  120007180361
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17858, KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K22719, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-17H05104
[Journal Article] Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma.2019
- Author(s)
  Miki H, Nakamura S, Oura M, Hamano H, Ikuta K, Okada N, Okamoto Y, Sogabe K, Takahashi M, Iwasa M, Udaka K, Harada T, Kurahashi K, Fujii S, Yoshida S, Kagawa K, Endo I, Aihara KI, Abe M.
- Journal Title
  
  British Journal of Haematology
  
  Volume: in press Issue: 2 Pages: 355-358
- DOI
  10.1111/bjh.15837
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09956, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K17858
[Journal Article] Polyclonal immunoglobulin recovery after autologous stem cell transplantation is an independent prognostic factor for survival outcome in patients with multiple myeloma2019
- Author(s)
  Ozaki S, Harada T, Yagi H, Sekimoto E, Shibata H, Shigekiyo T, Fujii S, Nakamura S, Miki H, Kagawa K, Abe M
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 1 Pages: 12-12
- DOI
  10.3390/cancers12010012
- NAID
  120006894614
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-19K17858
[Journal Article] Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA2018
- Author(s)
  Bat-Erdene Ariunzaya、Nakamura Shingen、Oda Asuka、Iwasa Masami、Teramachi Jumpei、Ashtar Mohannad、Harada Takeshi、Miki Hirokazu、Tenshin Hirofumi、Hiasa Masahiro、Fujii Shiro、Sogabe Kimiko、Oura Masahiro、Udaka Kengo、Kagawa Kumiko、Yoshida Sumiko、Aihara Ken-ichi、Kurahashi Kiyoe、Endo Itsuro、Abe Masahiro
- Journal Title
  
  British Journal of Haematology
  
  Volume: 印刷中 Issue: 5 Pages: 969-974
- DOI
  10.1111/bjh.15673
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11504, KAKENHI-PROJECT-18K08329, KAKENHI-PROJECT-17KK0169, KAKENHI-PROJECT-17H05104, KAKENHI-PROJECT-19K17858, KAKENHI-PROJECT-18K16118
[Presentation] 肝臓アミロイドーシスに対する超音波エラストグラフィを用いた非侵襲的診断法の有用性.2022
- Author(s)
  三木浩和, 中村信元, 中村昌史, 住谷龍平, 大浦雅博, 曽我部公子, 髙橋真美子, 丸橋朋子, 原田武志, 藤井志朗, 西尾進, 友成哲, 安倍正博
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] 形質細胞疾患における新型コロナワクチンの有効性2022
- Author(s)
  中村信元, 堀太貴, 中村昌史, 住谷龍平, 大浦雅博, 曽我部公子, 丸橋朋子, 髙橋真美子, 藤井志朗, 三木浩和, 原田武志, 安倍正博
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] RNA編集酵素ADAR1を標的にする1q増幅骨髄腫細胞に対する治療法の開発2022
- Author(s)
  原田武志, 住谷龍平, 小田明日香, 井上雄介, 大浦雅博, 曽我部公子, 丸橋朋子, 高橋真美子, 藤井志朗, 中村信元, 三木浩和, 天眞寛文, 日浅雅博, 寺町順平, 安倍正博
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] 骨髄腫細胞のプロテアソーム阻害薬への抵抗性の機序と温熱療法によるその克服の可能性2022
- Author(s)
  丸橋朋子, 三木浩和, 曽我部公子, 原田武志, 小田明日香, 中村信元, 中村昌史,住谷龍平, 大浦雅博, 高橋真美子, 藤井志朗, 安倍正博
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Local hyperthermia against extramedullary plasmacytomas: cooperation with proteasome inhibitors.2022
- Author(s)
  Tomoko Maruhashi, Hirokazu Miki, Kimiko Sogabe, Asuka Oda, Masafumi Nakamura, Ryohei Sumitani, Masahiro Oura, Mamiko Takahashi, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Masahiro Abe
- Organizer
  The 84th Annual Meeting of the Japanese Society of Hematology.
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] TAK1 阻害は骨髄腫の細胞間相互作用による骨破壊と薬剤耐性を改善する2022
- Author(s)
  寺町順平, 天真寛文, 日浅雅博, 小田明日香, 清水宗, 住谷龍平, 大浦雅博, 曽我部公子, 丸橋朋子, 藤井志朗, 中村信元, 三木浩和, 遠藤逸朗, 原田　武志, 安倍正博
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] 骨髄腫に対する抗体免疫療法へのTh1様γδT細胞の応用2022
- Author(s)
  井上雄介, 原田武志, 天眞寛文, 小田明日香, 住谷龍平, 大浦雅博, 曽我部公子, 丸橋朋子, 高橋真美子, 藤井志朗, 中村信元, 三木浩和, 日浅雅博, 寺町順平, 安倍正博
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] The importance of retaining physical functions to prevent SRE in multiple myeloma.2021
- Author(s)
  Hirokazu Miki, Shingen Nakamura, Masafumi Nakamura, Makiko Mizuguchi, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Hirofumi Hamano, Masateru Kondo, Naoto Okada, Yoshimi Bando, Itsuro Endo, Masahiro Abe
- Organizer
  第46回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Diagnostic efficacy of non-invasive ultrasound shear wave elastography for hepatic AL amyloidosis.2021
- Author(s)
  Hirokazu Miki, Shingen Nakamura, Shiro Fujii, Masafumi Nakamura, Makiko Mizuguchi, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Takeshi Harada, Kumiko Kagawa, Susumu Nishio, Tetsu Tomonari, Masahiro Abe
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Down-regulation of the IRF4-SLAMF7 axis in MM cells by CELMoDs and HDAC inhibition.2021
- Author(s)
  Yusuke Inoue, Takeshi Harada, Hirofumi Tenshin, Asuka Oda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Induction of elotuzumab’s ADCC activity by Th1-like γδ T cells towards osteoclasts as well as myeloma cells.2021
- Author(s)
  Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe
- Organizer
  EH2021 26th Congress of European Hematology Association
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Mechanisms for the resistance to proteasome inhibitors in myeloma cells: the role of PIM2 and Akt kinase activation and NRF2 accumulation2021
- Author(s)
  Kimiko Sogabe Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Asuka Oda, Yusuke Inoue, Ryohei Sumitani, Masahiro Oura, Shiro Fujii, Kumiko Kagawa, Hirofumi Tenshin, Jumpei Teramachi, Masaki Ri, Shinsuke Iida, Masahiro Abe
- Organizer
  第46回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Expansion of γδ T cells by CELMoDs and enhancement of their anti-myeloma effects by elotuzumab.2021
- Author(s)
  Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Rhohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Development of combinatory treatment of Th1-like　γδ T cells with elotuzumab against osteoclasts as well as myeloma cells.2021
- Author(s)
  Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Rhohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe
- Organizer
  第46回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Resumption of myeloma cell sensitivity to proteasome inhibitors by PIM and Akt inhibition2021
- Author(s)
  Kimiko Sogabe, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Asuka Oda, Yusuke Inoue, Ryohei Sumitani, Tomoko Maruhashi, Masahiro Oura, Shiro Fujii, Kumiko Kagawa, Hirofumi Tenshin, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe
- Organizer
  第83回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease.2021
- Author(s)
  Hirokazu Miki, Shingen Nakamura, Masafumi Nakamura, Makiko Mizuguchi, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Hirofumi Hamano, Masateru Kondou, Naoto Okada, Yoshimi Bando, Itsuro Endo, Masahiro Abe
- Organizer
  The 48th annual meeting of European Calcified Tissue Society (ECTS)
- Data Source
  KAKENHI-PROJECT-21K16244
[Presentation] Synergistic targeting of Sp1 in myeloma cells with hyperthermia plus proteasome inhibitors2019
- Author(s)
  Hirokazu Miki, Shingen Nakamura, Ariunzaya Bat-Erdene, Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, Shiyori Kawata, Taiki Hori, Jumpei Murai, Ryouhei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Kengo Udaka, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Masahiro Abe
- Organizer
  17th International Myeloma Workshop
- Data Source
  KAKENHI-PROJECT-19K17858
[Presentation] Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy2019
- Author(s)
  Takeshi Harada, Asuka Oda, Hirofumi Tenshin, Jumpei Teramachi, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Teru Hideshima, Kenneth C. Anderson, Masahiro Abe
- Organizer
  17th International Myeloma Workshop
- Data Source
  KAKENHI-PROJECT-19K17858
[Presentation] Novel therapeutic rationale for targeting HDAC1 and PIM2 in multiple myeloma2019
- Author(s)
  Takeshi Harada, Asuka Oda, Hiroto Ohguchi, Yohann Grondin, Hirofumi Tenshin, Masahiro Hiasa, Jumpei Teramachi, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Shuji Ozaki, Teru Hideshima, Kenneth C. Anderson, Masahiro Abe
- Organizer
  61th ASH Annual Meeting & Exposition
- Data Source
  KAKENHI-PROJECT-19K17858

1. ONO Rei

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. TERAMACHI Jyumpei

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 三木浩和

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
4. 安部正博

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Fujii Shiro 藤井 志朗

FUJII Shiro 藤井 志朗

Research Projects

Research Products

Co-Researchers

Suppression of tumor progression in multiple myeloma by osteogenic microenvironment: Elucidation of the molecular pathogenesis of tumor suppressing nichePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of acidic metabolism in multiple myeloma and the development of novel therapies targeting its acidic microenvironment.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] A Genome-Wide Association Study Predicts the Onset of Dysgeusia Due to Anti-cancer Drug Treatment2022

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Allogeneic haematopoietic stem cell transplantation?clinical outcomes: impact of leg muscle strength2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis2021

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement2021

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma.2020

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Correlation between high serum alkaline phosphatase levels and denosumab-related hypocalcemia in patients with multiple myeloma.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Polyclonal immunoglobulin recovery after autologous stem cell transplantation is an independent prognostic factor for survival outcome in patients with multiple myeloma2019

Author(s)

Journal Title

DOI

NAID

Data Source

[Journal Article] Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA2018

Fujii Shiro 藤井志朗

FUJII Shiro 藤井志朗

[Presentation] Development of combinatory treatment of Th1-like　γδ T cells with elotuzumab against osteoclasts as well as myeloma cells.2021